Metagenomi Therapeutics, Inc. - Common Stock (NQ:MGX)

0.8217 +0.0217 (+2.71%)

Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Metagenomi Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)

October 02, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, and New Fortress and Encourages Investors to Contact the Firm

October 01, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)

October 01, 2024

From Law Offices of Howard G. Smith

Via Business Wire

Peeling Back The Layers: Exploring Metagenomi Through Analyst Insights ↗

September 06, 2024

Via Benzinga

Unveiling 4 Analyst Insights On Metagenomi ↗

August 21, 2024

Via Benzinga

MGX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Metagenomi, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

October 01, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

September 30, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc. (MGX) Investors

September 30, 2024

From Law Offices of Frank R. Cruz

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc. (MGX) Investors

September 27, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

METAGENOMI ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Metagenomi, Inc. and Encourages Investors to Contact the Firm

September 27, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Metagenomi Inc. (MGX) Investors

September 27, 2024

From Kirby McInerney LLP

Via Business Wire

Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Metagenomi Inc.

September 27, 2024

From Robbins LLP

Via GlobeNewswire

MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the Schall Law Firm

September 27, 2024

From Schall Law

Via GlobeNewswire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc. (MGX) Investors

September 27, 2024

From Law Offices of Howard G. Smith

Via Business Wire

Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

September 27, 2024

From Rosen Law Firm

Via Business Wire

METAGENOMI, INC. (NASDAQ: MGX) INVESTOR ALERT: Investors With Large Losses in Metagenomi, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

September 27, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Metagenomi and Encourages Investors to Contact the Firm

September 20, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference

September 19, 2024

From Metagenomi, Inc.

Via GlobeNewswire

Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months

September 03, 2024

From Metagenomi, Inc.

Via GlobeNewswire

Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference

August 29, 2024

From Metagenomi, Inc.

Via GlobeNewswire

Metagenomi to Participate in Upcoming Investor Conferences

August 28, 2024

From Metagenomi, Inc.

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Metagenomi, Target Hospitality, Helios, and LegalZoom and Encourages Investors to Contact the Firm

August 26, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Cogent Communications To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday ↗

August 19, 2024

Via Benzinga

MGX Stock Earnings: Metagenomi Beats EPS, Beats Revenue for Q2 2024 ↗

August 14, 2024

MGX stock results show that Metagenomi beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results

August 14, 2024

From Metagenomi, Inc.

Via GlobeNewswire

Metagenomi, Inc. (MGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

August 11, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Dril-Quip, LPL Financial, Methode, and Metagenomi and Encourages Investors to Contact the Firm

August 05, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Metagenomi, Inc. (MGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

August 02, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

MGX Investors Have Opportunity to Join Metagenomi, Inc. Securities Fraud Investigation with the Schall Law Firm

July 30, 2024

From The Schall Law Firm

Via Business Wire

METAGENOMI ALERT: Bragar Eagel & Squire, P.C. is Investigating Metagenomi, Inc. on Behalf of Metagenomi Stockholders and Encourages Investors to Contact the Firm

July 18, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.